ImmunoGen Message Board - Msg: 33968130

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Gary Mohilner	8/19/2022 1:12:07 PM
	of 5665

Perhaps the first approval for IMGN may get some posters paying attention here, the PDUFA date is November 28th but I believe we could get early action from the FDA as they're familiar with the drug and pretty much dictated the terms of the Soraya trial which was successful. I have routinely been buying cheap calls and adding stock to my portfolio as they close well in the black on the stock rising. Today I'll add based on IMGN $5's for August and I've just purchased Sept. $7's. If I'm right my share count will equal the most I've ever held. With an approval I believe $10 to $15 or higher by year's end is almost guaranteed. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next